Navigation Links
Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference

DURHAM, N.C.--(BUSINESS WIRE)--Jul 3, 2007 - Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Wednesday, July 11, 2007 at 11:00 am ET in New York City.

The webcast of the presentation will be available on Inspire's web site at www.inspirepharm.com. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. Inspire employs a U.S. sales force for the promotion of AzaSite(TM) (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat(R) (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Inspire is focused on the therapeutic areas of ophthalmology and respiratory/allergy, and is developing products for dry eye, cystic fibrosis, allergic rhinitis and glaucoma. Elestat and Restasis are trademarks owned by Allergan, Inc. AzaSite is a trademark owned by InSite Vision Incorporated. For more information, visit www.inspirepharm.com.

Contact

Investor Contact:
Inspire Pharmaceuticals, Inc.
Jenny Kobin
VP, Investor Relations and Corporate Communications
919-941-9777, ext. 219
or
Media Contact:
BMC Communications
Dan Budwick, 212-477-9007 ext. 14


'"/>




Page: 1

Related medicine technology :

1. Inspire Announces Presentations at Two European Scientific Conferences
2. Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
3. Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2018)... , ... November 15, 2018 , ... According to Nielsen, ... year with a growth of 20 percent, as compared to only a 2 percent ... have already committed to exhibiting at Plant Based World Conference & Expo (PBW) taking ...
(Date:11/15/2018)... NASHVILLE, Tenn. (PRWEB) , ... November 15, 2018 ... ... anesthesia and pain management service provider, has completed a transaction with Grand Canyon ... a distinguished track record of high-quality care in the Phoenix area,” says Marty ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... will present at the upcoming Partnerships in Clinical Trials (PCT) conference at the ...
Breaking Medicine Technology:
(Date:11/16/2018)... ... , ... OnlineMasters.com, an industry-leading educational research organization, announces the ... have identified the top programs in the nation that are the best in ... an exclusive data set comprised of interviews and surveys from current students and ...
(Date:11/16/2018)... ... November 16, 2018 , ... ... with China Resources Microelectronics Limited (CR Micro) and China Resources Life Science ... of establishing two joint research centres for novel micro-electronic devices and precision ...
(Date:11/15/2018)... ... 2018 , ... Modern Acupuncture™, the first franchise to make ... accessible and affordable delivery, is now open in Bothell. Modern Acupuncture is the ... the country. , Located at 1427 228th Street in the Canyon Park neighborhood, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Made of Millions, a nonprofit organization that ... Seen — to New York this month. The event will feature a discussion on ... environment that showcases mental health issues in a more experiential way,” said Aaron Harvey, ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... Over the ... products, has raised more than $1.7 million for National Breast Cancer Foundation (NBCF) ... people to enjoy a safer lifestyle. The proceeds have helped launch the National ...
Breaking Medicine News(10 mins):